With the baxdrostat P3 to be published on 30th August, we show that AZN’s pipeline upside is underappreciated, in part due to the significant complexity & sheer volume of readouts. We also show that Imfinzi peak sales are likely too low; we are $2bn higher than consensus in 2029. We expect consensus forecasts to materially increase after the full baxdrostat data on the 30th August, we are ~$2bn higher than consensus and see upside risk to our forecasts. AZN’s catalyst path is one of the best in ...
We initiate on EnergyVision 40 days after its successful IPO. We believe that the positive vibe from the stock market entry will reflect in its future business development. Credibility and brand recognition are key for an energy supplier. We also like its focus on the energy transition. This segment recovers from an over-excitement period (2021-22). Today's market is all about AI and Defence, while climate change is becoming more apparent with every wild fire or glacier collapse. Their customer...
A director at Generali sold 44,000 shares at 33.571EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
A director at AstraZeneca sold 9,563 shares at 11,512p and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Rdos. 3T'25 vs 3T'24: Ventas: 19.337 M euros (+2,3% vs n/a BS(e) y +1,8% consenso); EBITA industrial ajustado: 2.820 M euros (-7,0% vs n/a BS(e) y -7,1% consenso); BDI: 2.243 M euros (+5,2% vs n/a BS(e) y -7,5% consenso). Rdos. 9meses'25 vs 9meses'24: Ventas: 57.488 M euros (+4,3% vs n/a BS(e) y +4,1% consenso); EBITA industrial ajustado: 8.576 M euros (+3,7% vs n/a BS(e) y +3,7% consenso); BDI: 8.550 M euros (+24,3% vs n/a BS(e) y +20,4% consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: EUROPA: ALLIANZ, DEUTSCHE TELEKOM, SIEMENS. Europa ignora a Trump Las últimas amenazas de D. Trump a la Eurozona con más aranceles no tuvieron ningún efecto en el mercado, que prosiguió la racha alcista con la que arrancó la semana y empujó al Ibex nuevamente a máximos de 2008. Así, en el STOXX 600 Energía e Inmobiliario fueron los sectores que más subieron frente a Farma y Tecnología que fueron los que más cayeron. Por el lado macro, en la Eurozona las ven...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.